The monthly meeting for the Association for Corporate Growth in Connecticut is Friday, June 2. This month the panel will discuss the benefits and growth opportunities regarding investing in the marijuana industry. They’ll also discuss potential obstacles.
A focus of the meeting will be cannabidiol, according to Business Wire. Cannabidiol may become a $2.1-billion market by 2020 as The Hemp Business Journal recently reported. This would be a 700-percent increase from 2016 projections.
Aaron W. Ford of Curaleaf LLC said, “We are encouraged that recent political developments have improved the scope and breadth of this industry, both across the U.S. and in Connecticut. The medical marijuana industry is growing exponentially. It can offer real opportunity to the savvy investor as it benefits the larger community, improves medical research and development, and spurs statewide job growth. I look forward to discussing the complexities, risks and other key factors related to this industry with my fellow panelists and with the engaged ACG community.”
ACG Connecticut President Mark Campbell said, “ACG is thrilled to host this panel of experts to discuss and demystify some of the complexity of investing in this dynamic industry. As Connecticut continues to develop its medical marijuana laws, this topic is growing in its importance to private equity as well as the community at large. We welcome ACG members and guests for this don’t-want-to-miss morning event, which should be one of the most interesting of the year.”
ACG Connecticut and young members can attend free. The fee for non-members is $75.00 for early bird pricing and $95.00 if you wait until closer to the event to purchase tickets. Members of other ACG chapters pay a $55.00 early bird ticket fee or $75 if they wait. Early bird registration ends May 31.